TECX
Tectonic Therapeutic, Inc.Company with tickers: TECX
CIK
1681087
CUSIP
878972108
Shares Outstanding
18,869,186
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $27,301,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $20,871,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-27,301,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-25,241,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-1.34 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-1.34 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |